Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)

Pipeline Summary for Products Targeting Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)

Print this Phases of Development Discovery Preclinical IND Pilot Phase I Phase I/II Phase II Phase II/III Pivotal Phase III Registration Approved Marketed Autoimmune 0 1 0 0 0 0 0 0 0 0 0 0 1 Cancer 2 9 1 0 12 3 7 1 0 1 1 3 2 Cardiovascular 1 0 0 0 0 0 0 0 1 0 0 1 4 Diagnostic 0 0 0 1 0 0 0 0 0 0 0 0 0 Gastrointestinal 0 0 0 0 0 0 0 0 0 0 0 0 1 Infectious 0 1 0 0 0 0 0 0 0 0 0 0 0 Inflammation 0 0 0 0 0 0 0 0 0 0 0 0 1 Neurology 0 0 0 0 0 0 0 0 0 0 0 0 1 Renal 0 1 0 0 0 0 0 0 0 1 0 0 0 Transplant 0 0 0 0 0 0 0 0 0 0 0 1 1 Copyright ©2013 BioCentury Publications, Inc. All Rights Reserved